Pro-Dex Inc. (PDEX) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks
Pro-Dex Inc. (PDEX)

An SI Board Since March 2000

Posts	SubjectMarks	Bans	Symbol
1	0	0	PDEX

Emcee: Manfred	Type: Unmoderated

Introduction Market Data Compact

Pro-Dex, Inc. is a holding company that operates in
the dental industry through four wholly owned
operating subsidiaries: Biotrol International, Inc.
(Biotrol), Challenge Products, Inc. (Challenge), Micro
Motors, Inc. (Micro), and Oregon Micro Systems,
Inc. (OMS).

Here is an extract from a news release of March 14th 2000:

"DENVER, March 9 /PRNewswire/ -- The following is being issued by Neidiger, Tucker, Bruner, Inc.,
a member of NASD Regulation, CRD #7425:

Pro-Dex's OMS Division (Nasdaq: PDEX - news) increased sales 397% in Q2 and has a current
annual revenue run rate of $10MM. NTB's analyst Michael Shonstrom notes that suppliers to the
semi-conductor equipment manufactures like Advanced Energy Devices (Nasdaq: AEIS - news) sell at
market capitalizations of 10x current revenues. Pro-Dex's total market capitalization is only $30MM or
3x the sales of its OMS Division alone.

Importantly, OMS's motion control circuit board technology is used by a number of equipment
makers including Applied Materials (Nasdaq: AMAT - news) and the company has developed proto-
types of compact PCI technology for next generation equipment. Additionally, OMS has expanded its
distribution into a number of new industry channels with PC104-based systems using Wagner Electric
servo-motors and controllers and mini-PCI card-based boards.

With the turnaround in its dental business now going on, NTB expects Q3 EPS of $0.04 versus a loss
of ($0.08) and $0.20 estimated for FY 00.

On its own, OMS should be valued at 4.0 run rate revenues with balance of the company valued at
1.0x sales. This results in a market value of $57MM and a target price of $6. With a return to
profitability, NTB has raised its rating to a BUY."

Some links:

pro-dex.com
biz.yahoo.com
biz.yahoo.com

Only 8,79 mil shares outstanding, float is very thin: 4,4 mil.

Stock just broke out and closed on a new 52 week high: 4 1/4

Manfred

Go to reply# or date (mm/dd/yy):